Patents by Inventor Michael Schlesinger

Michael Schlesinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11957746
    Abstract: The present invention in particular relates to a method of producing an immunogenic composition exhibiting reduced virucidal activity, as well as to the immunogenic composition and uses thereof, wherein the method in particular comprises the steps of: (a) providing a mixture with a first liquid and a recombinant protein, (b) concentrating the recombinant protein in the mixture by removing a portion of the first liquid from the mixture, and (c) processing the solution resulting from step (b) by continuous diafiltration.
    Type: Grant
    Filed: March 25, 2019
    Date of Patent: April 16, 2024
    Inventors: Leigh Wilmes, Matthew Coons, Amanda Brown, Michael Johannes Gassel, Francois-Xavier Orveillon, Katharina Hedwig Toepfer, Elida Bautista, Kathy Schlesinger
  • Patent number: 8617279
    Abstract: The present disclosure relates to an air box for an internal combustion engine, including a housing, having two suction openings as well as an outlet.
    Type: Grant
    Filed: December 20, 2011
    Date of Patent: December 31, 2013
    Inventors: Michael Schlesinger, Samuel Schinkel
  • Patent number: 8497299
    Abstract: The present invention relates to cannabinoic quinone compounds, and especially to their medical use. In particular five cannabinoic quinones, designated HU-331, HU-336, HU-345, HU-395 and HU-396, are described as active agents in pharmaceutical compositions. These compounds and compositions thereof are intended for the treatment of inflammatory, infectious, auto-immune and particularly hyperproliferative disorders. Thus, the compounds of the invention may be used as anti-tumor agents, or for the treatment of cancer. Furthermore, three of these compounds, HU-345, HU-395 and HU-396, are novel cannabinoic quinones.
    Type: Grant
    Filed: January 14, 2005
    Date of Patent: July 30, 2013
    Assignee: Yissum Research Development Company of The Hebrew University of Jerusalem
    Inventors: Raphael Mechoulam, Natalya M. Kogan, Ruth Rabinowitz, Michael Schlesinger
  • Publication number: 20120152200
    Abstract: The present disclosure relates to an air box for an internal combustion engine, comprising a housing, having two suction openings as well as an outlet.
    Type: Application
    Filed: December 20, 2011
    Publication date: June 21, 2012
    Applicant: SOLO Kleinmotoren GmbH
    Inventors: Michael Schlesinger, Samuel Schinkel
  • Publication number: 20110092584
    Abstract: The present invention relates to cannabinoic quinone compounds, and especially to their medical use. In particular five cannabinoic quinones, designated HU-331, HU-336, HU-345, HU-395 and HU-396 are herein described as active agents in pharmaceutical compositions. Said compounds and compositions thereof are intended for the treatment of inflammatory, infectious, auto-immune and particularly hyperproliferative disorders. Thus, the compounds of the invention may be used as anti-tumor agents, or for the treatment of cancer. Furthermore, three of these compounds, HU-345, HU-395 and HU-396, are novel cannabinoic quinones and thus are also claimed herein.
    Type: Application
    Filed: January 14, 2005
    Publication date: April 21, 2011
    Applicant: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM
    Inventors: Raphael Mechoulam, Natalya M. Kogan, Ruth Rabinowitz, Michael Schlesinger